In human neuroblastoma, the leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) belonging to the R-spondin receptor family, activates ERK1/2, which, together with the wingless/integrated (Wnt)/β-catenin pathway, contributes to tumor growth [46]. The gene discussed is LGR5; the disease is neoplasm.